NI201200140A - Hidrato del hidrocloruro de agomelatina y preparación de éste - Google Patents
Hidrato del hidrocloruro de agomelatina y preparación de ésteInfo
- Publication number
- NI201200140A NI201200140A NI201200140A NI201200140A NI201200140A NI 201200140 A NI201200140 A NI 201200140A NI 201200140 A NI201200140 A NI 201200140A NI 201200140 A NI201200140 A NI 201200140A NI 201200140 A NI201200140 A NI 201200140A
- Authority
- NI
- Nicaragua
- Prior art keywords
- preparation
- agomelatin
- hydrochloride hydrate
- hydrate
- present method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se proporciona un hidrato del hidrocloruro de agomelatina de fórmula (I), en la que X es Cl, preparación, uso y composición farmacéutica del mismo. Dicho hidrato obtenido mediante el presente método tiene una solubilidad significativamente aumentada que la agomelatina, y por ello es más adecuada para fabricar formulaciones farmacéuticas. Usando el presente método, se puede obtener una pureza elevada mediante de un proceso simple, sin ninguna etapa complicada.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010126254XA CN102190594A (zh) | 2010-03-17 | 2010-03-17 | 阿戈美拉汀氯化氢水合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201200140A true NI201200140A (es) | 2012-11-09 |
Family
ID=44599556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201200140A NI201200140A (es) | 2010-03-17 | 2012-09-12 | Hidrato del hidrocloruro de agomelatina y preparación de éste |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US8729131B2 (es) |
| EP (1) | EP2547649B1 (es) |
| JP (1) | JP5634532B2 (es) |
| KR (1) | KR101406727B1 (es) |
| CN (2) | CN102190594A (es) |
| AP (1) | AP2012006492A0 (es) |
| AU (1) | AU2011229618B2 (es) |
| BR (1) | BR112012023317B1 (es) |
| CA (1) | CA2792417C (es) |
| CL (1) | CL2012002540A1 (es) |
| CR (1) | CR20120462A (es) |
| CU (1) | CU20120137A7 (es) |
| CY (1) | CY1116086T1 (es) |
| DK (1) | DK2547649T3 (es) |
| EA (1) | EA022067B1 (es) |
| EC (1) | ECSP12012155A (es) |
| ES (1) | ES2530772T3 (es) |
| GE (1) | GEP20156231B (es) |
| GT (1) | GT201200259A (es) |
| HK (1) | HK1177451A1 (es) |
| HR (1) | HRP20150071T1 (es) |
| IL (1) | IL221782A (es) |
| MA (1) | MA34055B1 (es) |
| ME (1) | ME02054B (es) |
| MX (1) | MX2012010541A (es) |
| NI (1) | NI201200140A (es) |
| NZ (1) | NZ602450A (es) |
| PE (1) | PE20130013A1 (es) |
| PL (1) | PL2547649T3 (es) |
| PT (1) | PT2547649E (es) |
| RS (1) | RS53815B1 (es) |
| SG (1) | SG183868A1 (es) |
| SI (1) | SI2547649T1 (es) |
| TN (1) | TN2012000435A1 (es) |
| UA (1) | UA105425C2 (es) |
| WO (1) | WO2011113362A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2551257A1 (en) * | 2011-07-28 | 2013-01-30 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of agomelatine with co-crystal-formers |
| FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| CN102718675B (zh) * | 2012-06-07 | 2015-03-25 | 上海右手医药科技开发有限公司 | 阿戈美拉汀甲磺酸复合物及其制备方法 |
| CN102702041B (zh) * | 2012-05-14 | 2013-08-14 | 上海右手医药科技开发有限公司 | 阿戈美拉汀苯磺酸类复合物及其制备方法 |
| KR20150020191A (ko) * | 2012-05-14 | 2015-02-25 | 상하이 라이트핸드 팜테크 주식회사 | 아고멜라틴 산기 복합체와 그의 제조방법 및 용도 |
| CN102718676B (zh) * | 2012-06-26 | 2014-04-09 | 福建广生堂药业股份有限公司 | 阿戈美拉汀硫酸盐及其制备方法 |
| EP2934502A1 (en) | 2012-12-21 | 2015-10-28 | Laboratorios Lesvi S.L. | Process for prepararing n-(2-(7-methoxy-1-naphthalenyl)ethyl) acetamide and solid forms thereof |
| FR3001894A1 (fr) | 2013-02-08 | 2014-08-15 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| WO2015013865A1 (en) * | 2013-07-29 | 2015-02-05 | Les Laboratoires Servier | Agomelatine sulfonic acids complexes and preparation thereof |
| KR101470794B1 (ko) * | 2014-06-30 | 2014-12-08 | 순천향대학교 산학협력단 | 아고멜라틴 공결정의 제조 방법 및 이를 포함하는 조성물 |
| MX2018000179A (es) | 2015-07-02 | 2018-06-27 | Acerta Pharma Bv | Formas solidas y formulaciones de (s)-4-(8-amino-3-(1-(but-2-inoil )pirrolidin-2-il)imidazo[1,5-a]pirazin-1-il)-n-(piridin-2-il)benz amida. |
| US10193749B2 (en) * | 2016-08-27 | 2019-01-29 | Nicira, Inc. | Managed forwarding element executing in public cloud data compute node without overlay network |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| CZ20031397A3 (cs) * | 2000-10-30 | 2003-11-12 | Teva Pharmaceutical Industries Ltd. | Nové krystalické a solvatované formy ondansetron hydrochloridu a způsoby jejich přípravy |
| FR2890562B1 (fr) * | 2005-09-09 | 2012-10-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime |
| FR2899472B1 (fr) * | 2006-04-07 | 2008-09-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee |
| FR2934859B1 (fr) * | 2008-08-05 | 2010-08-13 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
| CN101481321B (zh) * | 2009-02-27 | 2012-04-18 | 上海医药工业研究院 | 阿戈美拉汀卤化氢复合物及其制备方法 |
| WO2012046253A2 (en) * | 2010-10-08 | 2012-04-12 | Msn Laboratories Limited | Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms |
-
2010
- 2010-03-17 CN CN201010126254XA patent/CN102190594A/zh active Pending
-
2011
- 2011-03-17 RS RS20150041A patent/RS53815B1/en unknown
- 2011-03-17 UA UAA201211720A patent/UA105425C2/ru unknown
- 2011-03-17 SI SI201130403T patent/SI2547649T1/sl unknown
- 2011-03-17 PL PL11755679T patent/PL2547649T3/pl unknown
- 2011-03-17 EA EA201201294A patent/EA022067B1/ru unknown
- 2011-03-17 EP EP11755679.5A patent/EP2547649B1/en active Active
- 2011-03-17 GE GEAP201112869A patent/GEP20156231B/en unknown
- 2011-03-17 JP JP2012557392A patent/JP5634532B2/ja not_active Expired - Fee Related
- 2011-03-17 US US13/635,063 patent/US8729131B2/en active Active
- 2011-03-17 SG SG2012065009A patent/SG183868A1/en unknown
- 2011-03-17 MA MA35192A patent/MA34055B1/fr unknown
- 2011-03-17 NZ NZ602450A patent/NZ602450A/en not_active IP Right Cessation
- 2011-03-17 WO PCT/CN2011/071910 patent/WO2011113362A1/en active Application Filing
- 2011-03-17 ME MEP-2015-23A patent/ME02054B/me unknown
- 2011-03-17 PE PE2012001448A patent/PE20130013A1/es active IP Right Grant
- 2011-03-17 AP AP2012006492A patent/AP2012006492A0/xx unknown
- 2011-03-17 DK DK11755679.5T patent/DK2547649T3/en active
- 2011-03-17 CN CN201180024357.8A patent/CN102958911B/zh not_active Expired - Fee Related
- 2011-03-17 CA CA2792417A patent/CA2792417C/en active Active
- 2011-03-17 PT PT117556795T patent/PT2547649E/pt unknown
- 2011-03-17 MX MX2012010541A patent/MX2012010541A/es active IP Right Grant
- 2011-03-17 BR BR112012023317-3A patent/BR112012023317B1/pt not_active IP Right Cessation
- 2011-03-17 ES ES11755679T patent/ES2530772T3/es active Active
- 2011-03-17 KR KR1020127026895A patent/KR101406727B1/ko active IP Right Grant
- 2011-03-17 AU AU2011229618A patent/AU2011229618B2/en not_active Ceased
-
2012
- 2012-08-31 TN TNP2012000435A patent/TN2012000435A1/en unknown
- 2012-09-04 IL IL221782A patent/IL221782A/en not_active IP Right Cessation
- 2012-09-11 CR CR20120462A patent/CR20120462A/es unknown
- 2012-09-12 NI NI201200140A patent/NI201200140A/es unknown
- 2012-09-13 CL CL2012002540A patent/CL2012002540A1/es unknown
- 2012-09-14 EC ECSP12012155 patent/ECSP12012155A/es unknown
- 2012-09-17 GT GT201200259A patent/GT201200259A/es unknown
- 2012-09-17 CU CU2012000137A patent/CU20120137A7/es unknown
-
2013
- 2013-04-16 HK HK13104588.5A patent/HK1177451A1/zh not_active IP Right Cessation
-
2015
- 2015-01-20 HR HRP20150071AT patent/HRP20150071T1/hr unknown
- 2015-01-22 CY CY20151100071T patent/CY1116086T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201200140A (es) | Hidrato del hidrocloruro de agomelatina y preparación de éste | |
| DOP2014000203A (es) | Compuestos de heterociclilo | |
| NZ704662A (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
| GT201500053A (es) | Composicion farmaceutica recubierta que contiene regorafenib | |
| NI201100163A (es) | Un complejo de haluro de hidrógeno de agomelatina y la preparación del mismo | |
| BR112013031493A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto. | |
| ECSP13013011A (es) | Triazolopiridinas | |
| BR112016011170A8 (pt) | derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica | |
| CL2017000293A1 (es) | Compuestos derivados de benzofurano sustituido en posición 6 por un radical que contiene boro; composición farmacéutica que los comprende; uso en el tratamiento de la hepatitis c (divisional del cl 393-2014) | |
| ECSP13012438A (es) | Proceso para preparar compuestos antivirales | |
| CL2011001405A1 (es) | Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina. | |
| BR112016028083A2 (pt) | Composição oral farmacêutica de isotretinoina e seu processo de preparação | |
| NI201200141A (es) | Hidrato del hidrobromuro de agomelatina y preparación de éste | |
| BR112012019866A8 (pt) | Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto | |
| MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| BR112015031820A2 (pt) | composto, composição farmacêutica, intermediário, processo para a preparação de um composto e métodos | |
| UA116994C2 (uk) | Стабілізована аморфна форма агомелатину, спосіб її одержання і фармацевтичні композиції, які її містять | |
| CO6551663A2 (es) | Hodrato del hidrocloruro de agomelatina y preparacion de este | |
| ES2403130R1 (es) | Forma polimorfica de clorhidrato de fexofenadina, compuestos intermedios y procedimiento para su preparacion | |
| WO2016027211A3 (en) | Process for the preparation of cinacalcet and its pharmaceutically acceptable salts | |
| UY35347A (es) | Formas cristalinas de un inhibidor de la prolil hidroxilasa | |
| IN2013MU02279A (es) | ||
| AR094866A1 (es) | Formas cristalinas de un inhibidor de la prolil hidroxilasa | |
| AR068977A1 (es) | Procedimiento para la preparacion de pentahidroxihexilcarbamoilundecanoato de bencilo y compuesto intermediario utilizado en la fabricacion del mismo |